Birdwatch Archive

Birdwatch Note Rating

2025-02-16 09:09:26 UTC - NOT_HELPFUL

Rated by Participant: 4F528F391FEBE5CF3AC3CAA7C28BCBB5DD23B35B84DC68CC1E3592F17FE84A7E
Participant Details

Original Note:

China’s advancements in diabetes treatment are promising, their integration into U.S. medical practice depends on thorough validation through clinical trials and regulatory approval. The suggestion that financial motivations are hindering adoption lacks substantiated evidence. https://medium.com/%40thechinaacademy/chinas-diabetes-cure-america-s-last-hope-15f231cdaec6

All Note Details

Original Tweet

All Information

  • noteId - 1890855351509221687
  • participantId -
  • raterParticipantId - 4F528F391FEBE5CF3AC3CAA7C28BCBB5DD23B35B84DC68CC1E3592F17FE84A7E
  • createdAtMillis - 1739696966588
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 1
  • notHelpfulIncorrect - 1
  • notHelpfulSourcesMissingOrUnreliable - 1
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 1
  • notHelpfulArgumentativeOrBiased - 1
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 1
  • notHelpfulIrrelevantSources - 1
  • notHelpfulOpinionSpeculation - 1
  • notHelpfulNoteNotNeeded - 1
  • ratingsId - 18908553515092216874F528F391FEBE5CF3AC3CAA7C28BCBB5DD23B35B84DC68CC1E3592F17FE84A7E